CRL Charles River Laboratories International

• $7,338 bought by 2 insiders
• $3M sold by 3 insiders outside a trading plan
• $49.1M sold by 3 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. James C Foster Director
   Planned sale
   $8.4M 24,042 shares at $350.00 43% of stake
   Traded Oct 22 Filed Oct 26
   ↗
3. Shannon M Parisotto CEVP, Disc & Safety Assessment
   Planned sale
   $743K 2,156 shares at $344.41 31% of stake
   Traded Oct 21 Filed Oct 23
   ↗
4. Shannon M Parisotto CEVP, Disc & Safety Assessment
   Planned sale
   $303K 981 shares at $308.44 17% of stake
   Traded Oct 5 Filed Oct 7
   ↗
5. Glenn Coleman CFO
   Buy
   $2,974 10 shares at $297.43 +<0.1% to stake
   Traded Sep 30 Filed Oct 2
   ↗
6. James C Foster Director
   Planned sale
   $10.1M 33,561 shares at $300.00 52% of stake
   Traded Aug 25 Filed Aug 27
   ↗
7. Shannon M Parisotto CEVP, Disc & Safety Assessment
   Planned sale
   $600K 2,039 shares at $294.12 30% of stake
   Traded Aug 19 Filed Aug 20
   ↗
8. Nancy C Andrews Director
   Sale
   $163K 573 shares at $285.24 29% of stake
   Traded Aug 18 Filed Aug 20
   ↗
9. Birgit Girshick CEO
   Planned sale
   $1.8M 6,500 shares at $279.90 15% of stake
   Traded Aug 11 Filed Aug 13
   ↗
10. Shannon M Parisotto CEVP, Disc & Safety Assessment
    Planned sale
    $1M 3,714 shares at $279.66 44% of stake
    Traded Aug 11 Filed Aug 13
    ↗
11. James C Foster Director
    Planned sale
    $7.9M 28,733 shares at $275.00 48% of stake
    Traded Aug 10 Filed Aug 11
    ↗
12. Michael Gunnar Knell SVP, Finance and CAO
    Sale
    $1.7M 6,645 shares at $260.38 36% of stake
    Traded Aug 6 Filed Aug 10
    ↗
13. Victoria L Creamer EVP & Chief People Officer
    Sale
    $1.1M 4,179 shares at $259.16 12% of stake
    Traded Aug 6 Filed Aug 10
    ↗
14. Shannon M Parisotto CEVP, Disc & Safety Assessment
    Planned sale
    $1.3M 5,046 shares at $263.00 51% of stake
    Traded Aug 5 Filed Aug 6
    ↗
15. James C Foster Director
    Planned sale
    $16.9M 75,000 shares at $225.00 70% of stake
    Traded Jun 29 Filed Jul 1
    ↗
16. Joseph W LaPlume EVP, Corp Strategy & Develop
    Buy
    $4,364 25 shares at $174.54 +0.1% to stake
    Traded Mar 3 Filed Mar 4
    ↗

Also filed in the last 12 months, not counted as buying or selling: 33 stock grants, 32 share withholdings for taxes, 17 gifts, and 14 option exercises.